Wound care management involves dressings, equipment, and other aids, such as bandages, gels, and ostomy drainage bags, designed to prevent and treat wounds, as well as to promote or accelerate wound healing. Oxygen Therapy is defined as a technique of delivering higher pressures of oxygen (100% oxygen under a pressure greater than one atmosphere) to the body’s tissues for the purpose of wound healing. GlobalData uses proprietary data and analytics to provide a comprehensive report on the oxygen therapy devices devices market, including market shares of different players within China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the oxygen therapy devices market in China was Yantai Hongyuan Oxygen Industry Group followed by Pommec Hytech, Sechrist Industries, Environmental Tectonics, Haux-Life-Support and Perry Baromedical.
There are two methods of administration: Systemic Oxygen Therapy (also known as Hyperbaric Oxygen Therapy, or HBOT) and Topical oxygen therapy. This includes Hyperbaric Oxygen Chambers.
The value of the oxygen therapy devices devices market within China was expected to be over $100m in 2023.
For the latest complete market share analysis of oxygen therapy devices device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
